Literature DB >> 15528025

Identification of high-risk pancreatic cancer-prone families.

Randall E Brand1, Henry T Lynch.   

Abstract

Pancreatic cancer-prone families provide a unique resource for studying the etiology, natural history, genetics, and treatment of pancreatic cancer. The only effective way of identifying these families is by obtaining a complete family history, since it is not possible to differentiate sporadic pancreatic cancer cases from hereditary cases based on either clinical presentation or features. These families also would benefit greatly from early detection or prevention strategies. Ultimately, this knowledge could be applied to the more common sporadic form of pancreatic cancer, where diagnosis is almost always late, and prognosis remains quite grim.

Entities:  

Mesh:

Year:  2004        PMID: 15528025     DOI: 10.1016/j.gtc.2004.07.011

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  5 in total

1.  A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: use of kras mutation molecular phenotyping to demonstrate independent primary origin.

Authors:  Maeve Lowery; David Klimstra; Cyrus Hedvat; William Jarnagin; Dennis Chi; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-03

2.  Role of BRCA1 and BRCA2 mutations in pancreatic cancer.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Gut       Date:  2006-09-14       Impact factor: 23.059

3.  Screening for pancreatic cancer: current evidence and future directions.

Authors:  Julia B Greer; Randall E Brand
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

4.  Identification of a novel kindred with familial pancreatitis and pancreatic cancer.

Authors:  Jennifer LaFemina; Penelope A Roberts; Yin P Hung; James F Gusella; Dushyant Sahani; Carlos Fernández-del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996

5.  Pancreatic cancer surveillance among high-risk populations: knowledge and intent.

Authors:  Zoe K Lewis; Caren J Frost; Vickie L Venne
Journal:  J Genet Couns       Date:  2009-03-05       Impact factor: 2.537

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.